Skip to content

Clinical trials

Phase 2 Obesity trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 2 Country / region: Spain Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20111
20121
20161
20173
20221
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Clinic of Barcelona3
Amgen2
Novo Nordisk A/S2
Eli Lilly and Company1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Gedeon Richter Plc.1
GlaxoSmithKline1
Goethe University1
Hoffmann-La Roche1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity17
Diabetes Mellitus, Type 25
Overweight5
Diabetes Mellitus2
Attention Deficit Disorder with Hyperactivity1
Fatty Liver1
Fibrosis1
Heart Failure1
Hyperglycemia1
Hypertension1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.